July 10, 2020 / 5:08 AM / a month ago

BRIEF-Sedana Medical: Positive Top Line Result In Pivotal IsoConDa Study

July 10 (Reuters) - Sedana Medical AB (publ):

* SEDANA MEDICAL ANNOUNCES POSITIVE TOP LINE RESULT IN PIVOTAL ISOCONDA STUDY

* STUDY REACHED ITS PRIMARY ENDPOINT; TO SHOW THAT ISOCONDA (ISOFLURANE), ADMINISTERED WITH ANACONDA, IS AN EFFECTIVE SEDATION METHOD, FOR VENTILATOR-INTENSIVE CARE PATIENTS, WHICH IS NON-INFERIOR TO PROPOFOL

* SECONDARY ENDPOINTS ARE UNDER ANALYSIS AND WILL BE PUBLISHED TOGETHER WITH PRIMARY ENDPOINT IN A SCIENTIFIC JOURNAL AFTER PEER-REVIEW.

* RESULTS INDICATE THAT ISOCONDA IS AN EFFECTIVE AND SAFE SEDATION METHOD AND WILL FORM BASIS FOR COMPANY’S APPLICATION FOR EUROPEAN MARKET APPROVAL LATER THIS AUTUMN. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below